Why Are Inhibrx Biosciences Shares Soaring 76% After Hours? - Inhibrx Biosciences (NASDAQ:INBX)

Inhibrx Biosciences shares surged nearly 76% in after-hours trading Thursday after the company reported positive Phase 2 trial results for its cancer drug Ozeki...